Shanghai Bolex Food Technology Co., Ltd. (SHA:603170)

Elevation Oncology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,618	2,573	2,311	2,026	1,569	900.51
Other Revenue	78.51	78.51	58.32	10.57	8.77	4.28
Revenue	2,696	2,651	2,369	2,037	1,578	904.79
Revenue Growth (YoY)	9.87%	11.91%	16.31%	29.10%	74.37%	21.79%
Cost of Revenue	1,813	1,787	1,594	1,343	1,090	618.82
Gross Profit	882.84	864.68	774.86	693.75	487.64	285.98
Selling, General & Admin	460.95	458.05	413.27	368.95	196.75	78.56
Research & Development	53.98	52.99	46.75	43.31	39.82	31.78
Other Operating Expenses	31.54	18.98	17.71	15.95	10.39	5.84
Operating Expenses	554.69	536.63	480.78	431.67	249.17	117.85
Operating Income	328.15	328.05	294.08	262.08	238.48	168.13
Interest Expense	-5.33	-7.04	-3.3	-4.22	-5.12	-4.4
Interest & Investment Income	7.72	8.87	4.96	3.79	4.31	0.95
Currency Exchange Gain (Loss)	0.64	0.64	1.46	-	-0.02	1.95
Other Non Operating Income (Expenses)	-1.26	-0.38	-0.14	0.56	-0.1	-0.07
EBT Excluding Unusual Items	329.93	330.13	297.07	262.21	237.54	166.55
Gain (Loss) on Sale of Investments	-	-	-0.17	-	-	-
Gain (Loss) on Sale of Assets	-0.06	-0.15	85.25	0.05	0.12	0.03
Asset Writedown	3.91	-	-	-0.02	-0	-
Other Unusual Items	23.49	23.75	27.36	33.04	10.83	4.9
Pretax Income	357.28	353.73	409.51	295.28	248.49	171.48
Income Tax Expense	89.73	86.37	98.27	64.78	53.7	37.36
Earnings From Continuing Operations	267.55	267.36	311.24	230.5	194.79	134.12
Minority Interest in Earnings	-36.86	-34.12	-10.2	-15.13	-9.38	0
Net Income	230.69	233.24	301.04	215.36	185.41	134.12
Net Income to Common	230.69	233.24	301.04	215.36	185.41	134.12
Net Income Growth	-19.20%	-22.52%	39.78%	16.15%	38.24%	64.57%
Shares Outstanding (Basic)	398	402	401	378	357	362
Shares Outstanding (Diluted)	398	402	401	378	357	362
Shares Change (YoY)	-1.09%	0.19%	6.23%	5.96%	-1.64%	-
EPS (Basic)	0.58	0.58	0.75	0.57	0.52	0.37
EPS (Diluted)	0.58	0.58	0.75	0.57	0.52	0.37
EPS Growth	-18.31%	-22.67%	31.58%	9.62%	40.54%	-
Free Cash Flow	149.97	155.81	-59.07	181.61	25.06	11.88
Free Cash Flow Per Share	0.38	0.39	-0.15	0.48	0.07	0.03
Dividend Per Share	0.400	0.400	0.375	0.250	-	-
Dividend Growth	6.67%	6.67%	50.00%	-	-	-
Gross Margin	32.75%	32.61%	32.71%	34.06%	30.91%	31.61%
Operating Margin	12.17%	12.37%	12.41%	12.87%	15.12%	18.58%
Profit Margin	8.56%	8.80%	12.71%	10.57%	11.75%	14.82%
Free Cash Flow Margin	5.56%	5.88%	-2.49%	8.92%	1.59%	1.31%
EBITDA	374.07	374.5	342.66	302.34	261.63	173.43
EBITDA Margin	13.88%	14.12%	14.46%	14.84%	16.58%	19.17%
D&A For EBITDA	45.91	46.45	48.59	40.26	23.16	5.3
EBIT	328.15	328.05	294.08	262.08	238.48	168.13
EBIT Margin	12.17%	12.37%	12.41%	12.87%	15.12%	18.58%
Effective Tax Rate	25.11%	24.42%	24.00%	21.94%	21.61%	21.79%
Revenue as Reported	2,696	2,651	2,369	2,037	1,578	904.79
Advertising Expenses	-	315.47	283.43	262.43	111.67	2.24

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.